Literature DB >> 10508033

Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates.

P Oster1, A Zanchi, S Cresti, M Lattanzi, F Montagnani, C Cellesi, G M Rossolini.   

Abstract

Erythromycin resistance rates were found to be increased, from 7.1 in 1993 to 32.8% in 1997, among community-acquired Streptococcus pneumoniae isolates from the Siena area of central Italy. Most of the erythromycin-resistant isolates carried ermAM determinants and were also resistant to josamycin and clindamycin, whereas a minority (5.8%) carried mefA determinants and remained susceptible to the latter drugs.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10508033      PMCID： PMC89509          DOI： 10.1128/AAC.43.10.2510

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  Heterogeneity of the streptokinase gene in group A streptococci.

Authors:  T T Huang; H Malke; J J Ferretti
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

2.  Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990.

Authors:  P Geslin; A Buu-Hoi; A Frémaux; J F Acar
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

Review 3.  Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

4.  Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.

Authors:  F Baquero; J A García-Rodríguez; J García de Lomas; L Aguilar
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

5.  Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci.

Authors:  H Seppälä; T Klaukka; R Lehtonen; E Nenonen; P Huovinen
Journal:  Clin Infect Dis       Date:  1995-12       Impact factor: 9.079

6.  Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995.

Authors:  A P Johnson; D C Speller; R C George; M Warner; G Domingue; A Efstratiou
Journal:  BMJ       Date:  1996-06-08

7.  Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Brazil from 1988 to 1992.

Authors:  J F Sessegolo; A S Levin; C E Levy; M Asensi; R R Facklam; L M Teixeira
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Emergence of drug-resistant pneumococcal infections in the United States.

Authors:  R F Breiman; J C Butler; F C Tenover; J A Elliott; R R Facklam
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

9.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

10.  Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993.

Authors:  J Verhaegen; Y Glupczynski; L Verbist; M Blogie; N Verbiest; J Vandeven; E Yourassowsky
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079
View more
  32 in total

1.  Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.

Authors:  F Fitoussi; C Doit; P Geslin; N Brahimi; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae.

Authors:  F Depardieu; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

3.  Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.

Authors:  M P Montanari; M Mingoia; E Giovanetti; P E Varaldo
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

4.  Impact of Antimicrobial Resistance on the Treatment of Invasive Pneumococcal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

5.  In vivo efficacy of the new ketolide telithromycin (HMR 3647) in murine infection models.

Authors:  A Bonnefoy; M Guitton; C Delachaume; P Le Priol; A M Girard
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

6.  Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.

Authors:  B D Gaynor; K A Holbrook; J P Whitcher; S O Holm; H C Jha; J S P Chaudhary; R C Bhatta; T Lietman
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

7.  Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance study.

Authors:  Kei Kasahara; Koichi Maeda; Keiichi Mikasa; Kenji Uno; Ken Takahashi; Mitsuru Konishi; Eiichiro Yoshimoto; Koichi Murakawa; Eiji Kita; Hiroshi Kimura
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

8.  Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002.

Authors:  M Rantala; S Huikko; P Huovinen; J Jalava
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 9.  Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E).

Authors:  Corné H W Klaassen; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

10.  Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites.

Authors:  Maria Rosario Amezaga; Philip E Carter; Phillip Cash; Hamish McKenzie
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.